Produkty 58652-04-3

CAS 58652-04-3 występuje w naszej ofercie pod nazwami: 1-Dehydrocorticosterone 21-Acetate, 1–Dehydrocorticosterone 21–acetate. Oferty producentów: TRC, GLPBio, MedChemExpress. Dostępne opakowania: 1g, 10mg, 25mg, 5mg, 50mg, 25 mg, 5 mg, 50 mg.

1-Dehydrocorticosterone 21-Acetate
TRC, MedChemExpress
  • opakowanie: 1g, 25 mg, 5 mg, 50 mg
  • Warianty: 6
od 547,25
Zobacz produkt
1–Dehydrocorticosterone 21–acetate
GLPBio
  • opakowanie: 10mg, 25mg, 5mg, 50mg
  • Warianty: 4
od 676,61
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate (CAS 58652-04-3) to związek chemiczny o wzorze sumarycznym C23H30O5 i masie molowej 386.5 g/mol. Nazwa systematyczna IUPAC: [2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate. InChIKey: AUJYIXRHRTVZNY-ZWFCQKKLSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H30O5
Masa molowa386.5 g/mol
Nazwa IUPAC[2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
InChIKeyAUJYIXRHRTVZNY-ZWFCQKKLSA-N
SMILESCC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 1-Dehydrocorticosterone 21-Acetate, orb3143479
Izomery (ten sam wzór sumaryczny)
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid C23H30O5
9a-methyl-3-octanoyl-6-[(E)-prop-1-enyl]-3,3a,4,8-tetrahydrofuro[3,2-g]isochromene-2,9-dione C23H30O5
[2-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O5
(1S,2S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,8,13,15-tetramethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C23H30O5
[2-[(8S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O5
[(8S,9S,10R,11S,13S,14S,16R)-11-hydroxy-10,13-dimethyl-3,17-dioxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl] butanoate C23H30O5
[2-[(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O5
[(8R,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] acetate C23H30O5
[(8S,9S,10R,13S,14S,17R)-17-acetyl-6-(hydroxymethyl)-13-methyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate C23H30O5
[2-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O5
[(6S,8R,9S,13S,14S,17S)-3-acetyloxy-6-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] acetate C23H30O5